Literature DB >> 6611506

Successful transplantation across major histocompatibility barrier of deoxyguanosine-treated embryonic thymus expressing class II antigens.

A R Ready, E J Jenkinson, R Kingston, J J Owen.   

Abstract

Foreign tissues grafted into healthy recipients are usually rejected by the hosts' immune system largely by means of major histocompatibility complex (MHC) products expressed on donor cells. During ontogeny, developing T lymphocytes acquire tolerance to self-MHC antigens and the thymus has been considered as the most likely site for the abrogation of self-reactive clones. We demonstrate here that embryonic thymus lobes, when organ cultured in the presence of deoxyguanosine, which is toxic to proliferating embryonic thymic lymphocytes but does not affect the epithelial framework, when transplanted to the kidney capsule of normal healthy histoincompatible mice, are not rejected despite their continued expression of both class I and class II donor MHC products but do not induce tolerance. This suggests that immunogenicity is not solely a function of MHC antigen expression but is also influenced by the type of cell upon which the antigens are expressed and, if the thymus is involved in the induction of tolerance to self-MHC products, this is a function of a component other than the epithelium, perhaps thymic dendritic cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611506     DOI: 10.1038/310231a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  33 in total

Review 1.  Review article: thymus organ cultures and T-cell receptor repertoire development.

Authors:  G Anderson; E J Jenkinson
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

2.  Rat thymic cultures: morphological and phenotypical characterization.

Authors:  A M Fontecha; A Alvarez; R Navarro; A Zapata; C Ardavin
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

3.  Multiple nitric oxide synthase systems in adult rat thymus revealed using NADPH diaphorase histochemistry.

Authors:  J E Downing
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

4.  Cloning of human thymic subcapsular cortex epithelial cells with T-lymphocyte binding sites and hemopoietic growth factor activity.

Authors:  S Mizutani; S M Watt; D Robertson; S Hussein; L E Healy; A J Furley; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

5.  Immunosuppression with cyclosporin A alters the thymic microenvironment.

Authors:  M Kanariou; R Huby; H Ladyman; M Colic; G Sivolapenko; I Lampert; M Ritter
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

6.  Influence of bone marrow-derived Ia-bearing cells on the selection of the T-cell repertoire.

Authors:  L A Matis; S E Heckford; D L Longo
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

7.  Survival of deoxyguanosine-treated fetal thymus allografts is prevented by priming with dendritic cells.

Authors:  M T Benson; G Buckley; E J Jenkinson; J J Owen
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

8.  Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.

Authors:  G B McDonald; D P Jewell
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

Review 9.  Induction of MHC-restricted specificity and tolerance in the thymus.

Authors:  D Lo; Y Ron; J Sprent
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

10.  Analyses of T-cell differentiation from hemopoietic stem cells in the G0 phase by an in vitro method.

Authors:  J Toki; T Kumamoto; H Ogata; M Kawamura; M Fukumoto; Y Yamamoto; S Than; M Inaba; Y Himeno
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.